Pdt Partners, LLC Intra Cellular Therapies, Inc. Transaction History

Pdt Partners, LLC

$981 Million
Q2 2024

A detailed history of Pdt Partners, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 35,218 shares of ITCI stock, worth $2.58 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

35,218

Previous 50,932 30.85%

Holding current value

$2.58 Million

Previous $3.52 Million 31.56%

% of portfolio

0.25%

Previous 0.35%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$64.76 - $79.84 $1.02 Million - $1.25 Million	-15,714 Reduced 30.85%	35,218 $2.41 Million
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $476,724 - $560,263	-7,406 Reduced 12.69%	50,932 $3.52 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $561,726 - $892,196	-12,114 Reduced 17.19%	58,338 $4.18 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $729 - $897	14 Added 0.02%	70,452 $3.67 Million
Q2 2023 Aug 14, 2023	SELL	$54.67 - $66.44 $515,428 - $626,396	-9,428 Reduced 11.8%	70,438 $4.46 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.08 Million - $1.41 Million	24,657 Added 44.66%	79,866 $4.32 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $1.84 Million - $2.27 Million	41,716 Added 309.17%	55,209 $2.92 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $576,151 - $809,445	13,493 New	13,493 $628,000
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $76,678 - $206,304	-6,229 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $896,697 - $4.75 Million	-123,512 Reduced 95.2%	6,229 $214,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $631,491 - $1.19 Million	84,537 Added 187.01%	129,741 $969,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $481,422 - $645,965	45,204 New	45,204 $587,000
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $2.01 Million - $2.71 Million	-115,700 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $276,730 - $465,294	-18,254 Reduced 13.63%	115,700 $2.44 Million
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $944,017 - $1.11 Million	66,154 Added 97.57%	133,954 $1.94 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $730,206 - $1.5 Million	67,800	67,800 $1.07 Million

Others Institutions Holding ITCI

# of Institutions

400

Shares Held

87.2M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account